LABORATORIOS FARMACEUT./ ES0157261019 /
30/05/2024 8:24:05 | Diferencia -0.45 | Volumen | Bid8:25:08 | Ask8:25:08 | Máximo del día | Price Change Band |
---|---|---|---|---|---|---|
87.95EUR | -0.51% | 0 Volumen de negocios: 0.00 |
87.75Volumen de oferta: 75 | 88.00Tamaño/ Volumen/ Formato de Ask: 75 | 87.95 | 87.95 |
GlobeNewswire
8:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
8:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
8:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
8:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
8:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página